Advertisements

Protalix BioTherapeutics Inc. (DE) (PLX) Stock Quote

Detailed Quote for Protalix BioTherapeutics Inc. (DE) (PLX)
$ 0.79   0.009 (+1.15%) Volume: 1.23m 3:59 PM EDT Oct 20, 2017
After Hours:  $ 0.79 0.00 (0.00%) Volume: 5.84k 4:36 PM EDT Oct 20, 2017
Today 5d 1m 3m 1y more
Last Price
0.79
Change $
0.009
Change %
1.15%
Tick
  
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
0.81
High
0.81
Low
0.765
Prev Close
0.781
Last Trade
10/20/17
Volume
1.23m
52 Wk Hi
1.51460003
52 Wk Low
0.25999999
Market Cap
105.35m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
133,355,039
EPS (TTM)
-0.629999995
PE Ratio
N/A
Exchange
NYSE American
News and Media for Protalix BioTherapeutics Inc. (DE) (PLX)
Sector News | Topic News
News for Protalix BioTherapeutics Inc. (DE) (PLX)
Thu, Oct 19, 2017
8:10 AM Today's Research Reports on Stocks to Watch: Spectrum Pharmaceuticals and Protalix BioTherapeutics - ACCESSWIRE IA
Wed, Oct 18, 2017
8:38 AM Protalix out-licenses Fabry candidate PRX-102 to Chiesi; shares ahead 38% premarket - SeekingAlpha
6:50 AM Protalix BioTherapeutics Enters into an Exclusive Ex-US Partnership with Chiesi Farmaceutici for the Development and Commercialization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease - GlobeNewswire
Sat, Sep 23, 2017
7:30 AM Biotech: The Big Payoff - SeekingAlpha
Wed, Sep 13, 2017
5:14 PM Protalix BioTherapeutics (PLX) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow - SeekingAlpha
Tue, Sep 12, 2017
9:17 AM In Search Of Better Cystic Fibrosis Treatments - SeekingAlpha
Fri, Sep 08, 2017
9:41 AM 2 Game-Changers In Therapeutic Proteins: Protalix's ProCellEx And\u00A0Prometic's PPPS - SeekingAlpha
Tue, Sep 05, 2017
7:30 AM Protalix Biotherapeutics to Present at the Rodman\u00A0&\u00A0Renshaw\u00A019th Annual Global Investment\u00A0Conference - GlobeNewswire
Wed, Aug 09, 2017
11:00 AM Protalix BioTherapeutics' (PLX) CEO Moshe Manor on Q2 2017 Results - Earnings Call Transcript - SeekingAlpha
7:08 AM Protalix BioTherapeutics misses by $0.02, beats on revenue - SeekingAlpha
7:00 AM Protalix BioTherapeutics Reports 2017 Second Quarter Results and Provides Corporate Update - GlobeNewswire
5:51 AM Investor Network: Protalix BioTherapeutics, Inc. to Host Earnings Call - ACCESSWIRE
5:50 AM Investor Network: Protalix BioTherapeutics, Inc. to Host Earnings Call - ACCESSWIRE
Mon, Jul 31, 2017
7:30 AM Protalix BioTherapeutics to Hold Second Quarter 2017 Financial Results and Corporate Update Conference Call on August 9, 2017 - GlobeNewswire
Tue, Jul 25, 2017
4:27 PM Protalix BioTherapeutics Completes Private Note Exchange of $9 million Notes Maturing September 2018 for $8.55 million Notes Maturing February 2022 - GlobeNewswire
Thu, Jul 20, 2017
4:50 PM Protalix Is Undervalued With Upcoming Catalysts - SeekingAlpha
Mon, Jul 03, 2017
6:55 AM Wall Street Breakfast: Tesla Gears Up For Model 3 - SeekingAlpha
Fri, Jun 30, 2017
7:54 AM ProCellEx Has The Potential To Upend The Biopharmaceutical Sector - SeekingAlpha
Sat, Jun 24, 2017
8:58 AM Stocks to watch next week - SeekingAlpha
Wed, Jun 21, 2017
7:38 AM Amicus Therapeutics: Elucidating The Bullish And Bearish Claims - SeekingAlpha
More News for PLX >>

Tags for Protalix BioTherapeutics Inc. (DE)

Research stocks or mutual funds related to Protalix BioTherapeutics Inc. (DE) by keywords or tags. Find companies that have a similar focus to PLX. The keywords below have been associated to PLX by either user submission or electronic means.

biotechnology company biotech research pharmaceuticals research pharmaceuticals international research patent market pharmaceutical market corporate communication generic pharmaceutical pharmaceutical investment pharma strategy biotechnology market pharmaceutical research and development annual report pharmaceutical manufacturing company dupont pharmaceuticals pharmaceutical advisory boards Biological Products pharma marketing pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharma license pharmaceutical supply chain kv pharmaceutical company clinical research pharmaceutical cro pharmaceutical sales pharmaceutical distributors biotech corporation pharmaceutical development pharmaceutical sales rep pharmaceutical reports pharmaceutical magazine pharma product development pharmaceutical patent Drugs pharmaceutical industry news pharmaceutical manufacturing software corporate communications pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation pharma reports publicity contract pharmaceutical pharmaceutical consulting pharmaceutical industry news release pharmaceutical studies pharmaceutical strategy